Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive

Fertility and Sterility

Volumn 85, Issue 1, 2006, Pages 57-62

  Roumen, Frans J M E ^a   Dieben, Thom O M ^b,c  

^a Sittard Geleen Heerlen   (Netherlands)

^b Clinical Development Department   (Netherlands)

^c NV ORGANON   (Netherlands)

Author keywords

Ethinyl estradiol; Etonogestrel; Hysterectomy; NuvaRing; Oral contraceptive; Tissue concentration; Uterus

Indexed keywords

DESOGESTREL PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL; ETONOGESTREL;

ADULT; ALLERGY; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; DRUG TOLERABILITY; DYSMENORRHEA; ENDOMETRIUM; FEMALE; GYNECOLOGIC CARE; HEADACHE; HUMAN; HYSTERECTOMY; INSOMNIA; INTERMETHOD COMPARISON; LEUKORRHEA; MASTALGIA; MYOMETRIUM; NAUSEA; OBSTETRIC CARE; ORAL CONTRACEPTION; PHASE 3 CLINICAL TRIAL; PREMENOPAUSE; PRIORITY JOURNAL; PURPURA; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX; VAGINA CONTRACEPTION; VAGINA RING;

ADMINISTRATION, INTRAVAGINAL; ADULT; CONTRACEPTIVE DEVICES, FEMALE; CONTRACEPTIVES, ORAL, COMBINED; DESOGESTREL; ESTROGENS; ETHINYL ESTRADIOL; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; PROGESTERONE CONGENERS; TISSUE DISTRIBUTION; UTERUS;

EID: 30344441545     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2005.06.040     Document Type: Article

References (17)

1. M. Rosenberg, M.S. Waugh Causes and consequences of oral contraceptive noncompliance Am J Obstet Gynecol 180 1999 S276 S279
2. R.T. Burkman Oral contraceptives current status Clin Obstet Gynecol 44 2001 62 72
3. T.O. Dieben, F.J. Roumen, D. Apter Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring Obstet Gynecol 100 2002 585 593
4. F.J. Roumen, D. Apter, T.M. Mulders, T.O. Dieben Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol Hum Reprod 16 2001 469 475
5. K. Oddsson, B. Leifels Fischer, N. de Melo, D. Wiel Masson, C. Benedetto, C. Verhoeven Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive a 1-year randomized trial Contraception 71 2005 176 182
6. R.I. Bjarnadottir, M. Tuppurainen, S.R. Killick Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ ethinyl estradiol Am J Obstet Gynecol 186 2002 389 395
7. K. Oddsson, B. Leifels Fischer, D. Wiel Masson, N. de Melo, C. Benedetto, C. Verhoeven Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 ug ethinyl estradiol and 150 ug levonorgestrel a randomized trial Hum Reprod 20 2005 557 562
8. N.J. Alexander, E. Baker, M. Kaptein, U. Karck, L. Miller, E. Zampaglione Why consider vaginal drug administration? Fertil Steril 82 2004 1 12
9. C.J. Timmer, T.M. Mulders Pharmacokinetics of etonogestrel and ethinyl estradiol released from a combined contraceptive vaginal ring Clin Pharmacokinet 39 2000 233 242
10. H. Porias, I. Sojo, A. Carranco, R. Gonzalez-Martinez, V. Cortes-Gallegos A simultaneous assay to quantitate plasma and endometrial hormone concentrations Fertil Steril 30 1978 66 69
11. V. Cortes-Gallegos, A. Carranco, I. Sojo, M. Navarrette, C. Cervantes, A. Parra Accumulation of ethinyl estradiol in blood and endometrium of women taking oral contraceptives the sequential therapy Fertil Steril 32 1979 524 527
12. V. Cortes-Gallegos, A. Carranco, I. Sojo, M. Navarrete, C. Juarez-Carranza Ethynyl-estradiol (EE-2) content in blood and endometrium caused by oral contraceptives J Steroid Biochem 12 1980 487 489
13. R. Fanchin, D. De Ziegler, C. Bergeron, C. Righini, C. Torrisi, R. Frydman Transvaginal administration of progesterone Obstet Gynecol 90 1997 396 401
14. D. De Ziegler, C. Bulletti, B. De Monstier, A.S. Jaaskelainen The first uterine pass effect Ann N Y Acad Sci 828 1997 291 299
15. C. Bulletti, D. De Ziegler, E. Giacomucci, V. Polli, S. Rossi, S. Alfieri Vaginal drug delivery the first uterine pass effect Ann N Y Acad Sci 828 1997 285 290
16. N. Einer-Jensen, E. Cicinelli, P. Galantino, V. Pinto, B. Barba Uterine first pass effect in postmenopausal women Hum Reprod 17 2002 3060 3064
17. E. Cicinelli, D. De Ziegler, S. Morgese, C. Bulletti, D. Luisi, L.M. Schonauer "First uterine pass effect" is observed when estradiol is placed in the upper but not lower third of the vagina Fertil Steril 81 2004 1414 1416